History
  • No items yet
midpage
Roche Molecular Systems, Inc. v. Foresight Diagnostics Inc.
5:24-cv-03972
| N.D. Cal. | Jul 16, 2025
Read the full case

Background

  • Roche Molecular Systems, Inc. ("Roche") accuses three former consultants, now Stanford oncologists, of misappropriating trade secrets to develop competing cancer detection technology while still working for Roche.
  • The doctors formed Foresight Diagnostics Inc. ("Foresight") and collaborated with Stanford, which licensed the technology to Foresight.
  • Roche alleges Stanford also misappropriated its trade secrets and improperly claims ownership of certain patent applications derived from Roche technology.
  • Stanford sought to dismiss Roche's first amended complaint, challenging trade secret and ownership claims.
  • The decision addresses Stanford's motion to dismiss under Rule 12(b)(6), focusing on whether Roche has stated plausible claims against Stanford.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Trade secret misappropriation by Stanford (Counts 1 & 2) Stanford knew or should have known about improper acquisition; doctors’ knowledge imputed to Stanford Allegations are conclusory; no facts supporting Stanford’s knowledge or misappropriation Dismissed with leave to amend
Identification and timeliness of trade secrets Trade secrets sufficiently identified and claims timely Claims time-barred, trade secrets not identified Motion denied re: these arguments
Declaratory judgment regarding patent ownership (Count 10) There is an active controversy about patent ownership No subject matter jurisdiction; no justiciable controversy Motion denied; claim stated
Incorporation of Stanford Policies into complaint N/A Stanford policies preclude Roche’s ownership claim Not incorporated; court does not consider policies

Key Cases Cited

  • Ashcroft v. Iqbal, 556 U.S. 662 (pleading standard for facial plausibility)
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (standard for stating a claim under Rule 12(b)(6))
  • Lopez v. Smith, 203 F.3d 1122 (leave to amend should generally be granted unless amendment is futile)
  • Manzarek v. St. Paul Fire & Marine Ins. Co., 519 F.3d 1025 (pleading accepted as true on a motion to dismiss)
  • Fayer v. Vaughn, 649 F.3d 1061 (courts need not accept legal conclusions as true in ruling on motions to dismiss)
  • InteliClear, LLC v. ETC Glob. Holdings, Inc., 978 F.3d 653 (elements and pleading standards for trade secret misappropriation)
Read the full case

Case Details

Case Name: Roche Molecular Systems, Inc. v. Foresight Diagnostics Inc.
Court Name: District Court, N.D. California
Date Published: Jul 16, 2025
Docket Number: 5:24-cv-03972
Court Abbreviation: N.D. Cal.